Serum CCL23 has been implicated in multiple inflammatory diseases, such as systemic sclerosis, chronic rhinosinusitis, chronic kidney disease, and atherosclerotic disease [18,24,25,26]. This evidence concerns the gene CCL23 and chronic kidney disease.